Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis

被引:0
|
作者
Kai-Wei Wu
Corinne Sweeney
Narendar Dudhipala
Prit Lakhani
Narayan D. Chaurasiya
Babu L. Tekwani
Soumyajit Majumdar
机构
[1] The University of Mississippi,Department of Pharmaceutics and Drug Delivery
[2] Department of Infectious Diseases,undefined
[3] Division of Drug Discovery,undefined
[4] Research Institute of Pharmaceutical Sciences,undefined
[5] University of Mississippi,undefined
来源
关键词
Primaquine; Lipid-based formulation(s); Particle size; In vitro release; Stability; Ex vivo hemolysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis
    Wu, Kai-Wei
    Sweeney, Corinne
    Dudhipala, Narendar
    Lakhani, Prit
    Chaurasiya, Narayan D.
    Tekwani, Babu L.
    Majumdar, Soumyajit
    [J]. AAPS PHARMSCITECH, 2021, 22 (07)
  • [2] Correction to: Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis
    Kai-Wei Wu
    Corinne Sweeney
    Narendar Dudhipala
    Prit Lakhani
    Narayan D. Chaurasiya
    Babu L. Tekwani
    Soumyajit Majumdar
    [J]. AAPS PharmSciTech, 23
  • [3] Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis (vol 22, 240, 2021)
    Wu, Kai-Wei
    Sweeney, Corinne
    Dudhipala, Narendar
    Lakhani, Prit
    Chaurasiya, Narayan D.
    Tekwani, Babu L.
    Majumdar, Soumyajit
    [J]. AAPS PHARMSCITECH, 2022, 23 (01)
  • [4] In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
    Costa, Claudia Pina
    Barreiro, Sandra
    Moreira, Joao Nuno
    Silva, Renata
    Almeida, Hugo
    Sousa Lobo, Jose Manuel
    Silva, Ana Catarina
    [J]. PHARMACEUTICALS, 2021, 14 (08)
  • [5] Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
    Andonova, Velichka
    Peneva, Petya
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6630 - 6642
  • [6] Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate
    Üner, M
    Wissing, SA
    Yener, G
    Müller, RH
    [J]. PHARMAZIE, 2005, 60 (08): : 577 - 582
  • [7] Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art
    Silva, Ana Catarina
    Amaral, Maria Helena
    Sousa Lobo, Jose Manuel
    Almeida, Hugo
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6551 - 6552
  • [8] Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
    Müller, RH
    Radtke, M
    Wissing, SA
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 : S131 - S155
  • [9] Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)
    Fang, Jia-You
    Fang, Chia-Lang
    Liu, Chi-Hsien
    Su, Yu-Han
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 633 - 640
  • [10] Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
    Shastri, Divyesh H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6592 - 6601